Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood

Abstract

Myelodysplastic syndrome (MDS) in childhood is rare and has an estimated incidence per year of about 0.8-1.8 per million children aged 0 to 14 years.

Keywords

• grade myelodysplastic syndromes
• european leukemianet
• working group
• standardization
• validation